Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Non-cash Items (2020 - 2021)

Historic Non-cash Items for Avidity Biosciences (RNA) over the last 2 years, with Q4 2021 value amounting to $59.0 million.

  • Avidity Biosciences' Non-cash Items fell 942.2% to $59.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $59.0 million, marking a year-over-year decrease of 942.2%. This contributed to the annual value of $59.0 million for FY2021, which is 942.2% down from last year.
  • According to the latest figures from Q4 2021, Avidity Biosciences' Non-cash Items is $59.0 million, which was down 942.2% from $65.1 million recorded in Q4 2020.
  • Avidity Biosciences' Non-cash Items' 5-year high stood at $65.1 million during Q4 2020, with a 5-year trough of $59.0 million in Q4 2021.